Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Clinical Therapeutics|February 4, 2016
Daclatasvir and Sofosbuvir Versus Sofosbuvir and Ribavirin in Patients with Chronic Hepatitis C Coinfected with HIV: A Matching-adjusted Indirect ComparisonElyse Swallow, Jinlin Song, Yong Yuan, et al.
Therapeutic Advances in Hematology|July 19, 2023
Avatrombopag treatment response in patients with immune thrombocytopenia: the REAL-AVA 1.0 studyAbiola Oladapo, Scott Kolodny, Michael Vredenburg, et al.
Advances in Therapy|March 9, 2021
Risk of Chronic Kidney Disease and Estimated Glomerular Filtration Rate Decline in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort StudyElvira O Gosmanova, Kristina Chen, Lars Rejnmark, et al.
Clinical Genitourinary Cancer|November 16, 2019
Real-world Clinical Outcomes of Pazopanib Immediately After Discontinuation of Immunotherapy for Advanced Renal Cell CarcinomaXiting Cao, Derek Tang, Barbara Ratto, et al.
Advances in Therapy|June 24, 2021
Risk of Cardiovascular Conditions in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort StudyElvira O Gosmanova, Kristina Chen, Markus Ketteler, et al.
Multiple Sclerosis and Related Disorders|February 15, 2023
Comparative efficacy and safety of ozanimod and ponesimod for relapsing multiple sclerosis: A matching-adjusted indirect comparisonElyse Swallow, Timothy Pham, Oscar Patterson-Lomba, et al.
Journal of Drugs in Dermatology : JDD|August 7, 2025
Comparative Efficacy of Deucravacitinib and Adalimumab for Scalp Psoriasis: An Indirect Treatment ComparisonVardhaman Patel, Alexa Hetzel, Sang Hee Park, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 6, 2021
Confirmed disability progression provides limited predictive information regarding future disease progression in multiple sclerosisBrian C Healy, Bonnie I Glanz, Elyse Swallow, et al.
Journal of Comparative Effectiveness Research|January 18, 2020
Comparative safety and efficacy of ozanimod versus fingolimod for relapsing multiple sclerosisElyse Swallow, Oscar Patterson-Lomba, Lei Yin, et al.
Therapeutic Advances in Neurological Disorders|June 10, 2024
Comparative effectiveness and safety of ozanimod versus other oral DMTs in relapsing-remitting multiple sclerosis: a synthesis of matching-adjusted indirect comparisonsDamemarie Paul, Elyse Swallow, Oscar Patterson-Lomba, et al.
Pageof 7